Cargando...
Omics-based Biomarkers for the Early Alzheimer Disease Diagnosis and Reliable Therapeutic Targets Development
BACKGROUND: Alzheimer’s disease (AD), the most common cause of dementia in adulthood, has great medical, so-cial, and economic impact worldwide. Available treatments result in symptomatic relief, and most of them are indicated from the early stages of the disease. Therefore, there is an increasing b...
Guardado en:
| Publicado en: | Curr Neuropharmacol |
|---|---|
| Autores principales: | , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Bentham Science Publishers
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6712290/ https://ncbi.nlm.nih.gov/pubmed/30255758 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2174/1570159X16666180926123722 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|